Differential regulation of K+ and Ca2+ channel gene expression by chronic treatment with estrogen and tamoxifen in rat aorta

European Journal of Pharmacology

Volumn 483, Issue 2-3, 2004, Pages 155-162

  Tsang, Suk Ying ^a   Yao, Xiaoqiang ^a   Wong, Chi Ming ^a   Chan, Franky Leung ^b   Chen, Zhen Yu ^b   Huang, Yu ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

(Rat); Ca2+ channel; Estrogen; Gene expression; K+ channel; Ovariectomy; Tamoxifen

Indexed keywords

CALCIUM CHANNEL; ESTROGEN; ION CHANNEL; MESSENGER RNA; POTASSIUM CHANNEL; PROTEIN SUBUNIT; TAMOXIFEN; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; INTERMETHOD COMPARISON; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0347318095     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.10.031     Document Type: Article

References (47)

1. Andersen H.L., Jweis J.U., Fjalland B., Korsgaard N. Effect of acute and long-term treatment with 17β-estradiol on the vasomotor responses in the rat aorta. Br. J. Pharmacol. 126:1999;159-168.
2. Andersson C., Lydrup M.L., Ferno M., Idvall I., Gustafsson J., Nilsson B.O. Immunocytochemical demonstration of oestrogen receptor β in blood vessels of the female rat. J. Endocrinol. 169:2001;241-247.
3. Archer S.L., Huang J.M.C., Reeve H.L., Hampl V., Tolarova S., Michelakis E.D., Weir G.K. Differential distribution of electrophysiologically distinct myocytes in conduit and resistance arteries determines their response to nitric oxide and hypoxia. Circ. Res. 78:1996;431-442.
4. Barrett-Connor E., Bush T.L. Estrogen and coronary heart disease in women. JAMA. 265:1991;1861-1867.
5. + channel currents in rat aortic myocytes. Cardiovasc. Res. 54:2002;152-161.
6. Benkusky N.A., Korovkina V.P., Brainard A.M., England S.K. Myometrial maxi-K channel β1 subunit modulation during pregnancy and after 17β-estradiol stimulation. FEBS Lett. 524:2002;97-102.
7. V channels in coronary and pulmonary vascular muscle. Am. J. Physiol. 275:1998;H1351-H1359.
8. Bowyer L., Brown M.A., Jones M. Vascular reactivity in men and women of reproductive age. Am. J. Obstet. Gynecol. 185:2001;88-96.
9. Cacciatore B., Paakkari I., Hasselblatt R., Nieminen M.S., Toivonen J., Tikkanen M.I., Ylikorkala O. Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women. Am. J. Obstet. Gynecol. 184:2001;904-909.
10. Cagnacci A., Rovati L., Zanni A., Malmusi S., Facchinetti F., Volpe A. Physiological doses of estradiol decrease nocturnal blood pressure in normotensive postmenopausal women. Am. J. Physiol. 276:1999;H1355-H1360.
11. Chan H.Y., Yao X., Tsang S.Y., Chan F.L., Lau C.W., Huang Y. Different role of endothelium/nitric oxide in 17β-estradiol- and progesterone- induced relaxation in rat arteries. Life Sci. 69:2001;1609-1617.
12. Cheong A., Dedman A.M., Beech D.J. Expression and function of native potassium channel Kv α1 subunits in terminal arterioles of rabbit. J. Physiol. 534:2001;691-700.
13. + current. J. Physiol. 515:1999;653-667.
14. Collins P., Rosano G.M., Jiang C., Lindsay D., Sarrel P.M., Poole-Wilson P.A. Cardiovascular protection by oestrogen - a calcium antagonist effect? Lancet. 341:1993;1264-1265.
15. V channel α- and β-subunits in the bovine pulmonary arterial circulation. Am. J. Physiol., Lung Cell. Mol. Physiol. 281:2001;L1350-L1360.
16. Cox R.H., Lozinskaya I.M. Augmented calcium currents in mesenteric artery branches of the spontaneously hypertensive rat. Hypertension. 26:1995;1060-1064.
17. + channel genes in arteries from spontaneously hypertensive and Wistar Kyoto rats. Hypertension. 37:2001;1315-1322.
18. Figtree G.A., Webb C.M., Collins P. Tamoxifen acutely relaxes coronary arteries by an endothelium-, nitric oxide-, and estrogen receptor-dependent mechanism. J. Pharmacol. Exp. Ther. 295:2000;519-523.
19. Gonzales R.J., Walker B.R., Kanagy N.L. 17β-Estradiol increases nitric oxide-dependent dilation in rat pulmonary arteries and thoracic aorta. Am. J. Physiol., Lung Cell. Mol. Physiol. 280:2001;L555-L564.
20. Hutchison S.J., Chou T.M., Chatterjee K., Sudhir K. Tamoxifen is an acute, estrogen-like, coronary vasodilator of porcine coronary arteries in vitro. J. Cardiovasc. Pharmacol. 38:2001;657-665.
21. Johnson B.D., Zheng W., Korach K.S., Scheuer T. Increased expression of the cardiac L-type calcium channel in estrogen receptor-deficient mice. J. Gen. Physiol. 110:1997;135-140.
22. Karas R.H., Patterson B.L., Mendelsohn M.E. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation. 89:1994;1943-1950.
23. Kitazawa T., Hamada E., Kitazawa K., Gaznabi A.K. Non-genomic mechanism of 17 β-oestradiol-induced inhibition of contraction in mammalian vascular smooth muscle. J. Physiol. 499:1997;497-511.
24. Korovkina V.P., England S.K. Molecular diversity of vascular potassium channel isoforms. Clin. Exp. Pharmacol. Physiol. 29:2002;317-323.
25. + channels in genetic and nongenetic hypertension. Circ. Res. 79:1996;295-301.
26. Michelaskis E.D., Reeve H.L., Huang J.M., Tolarova S., Nelson D.P., Weir E.K., Archer S.L. Potassium channel diversity in vascular smooth muscle cells. Can. J. Physiol. Pharm. 75:1997;889-897.
27. 2+ currents in aortic smooth muscle cells. Eur. J. Pharmacol. 294:1995;625-635.
28. Nelson M.T., Quayle J.M. Physiological roles and properties of potassium channels in arterial smooth muscle. Am. J. Physiol., Cell Physiol. 268:1995;C799-C822.
29. Nevala R., Paukku K., Korpela R., Vapaatalo H. Calcium-sensitive potassium channel inhibitors antagonize genistein- and daidzein-induced arterial relaxation in vitro. Life Sci. 69:2001;1407-1417.
30. Ogata R., Inoue Y., Nakano H., Ito Y., Kitamura K. Oestradiol-induced relaxation of rabbit basilar artery by inhibition of voltage-dependent Ca channels through GTP-binding protein. Br. J. Pharmacol. 117:1996;351-359.
31. + channels in rabbit aorta and vas deferens smooth muscle. Pflügers Arch. 441:2001;611-620.
32. Patterson E., Ma L., Szabo B., Robinson C.P., Thadani U. Ovariectomy and estrogen-induced alterations in myocardial contractility in female rabbits: role of the L-type calcium channel. J. Pharmacol. Exp. Ther. 284:1998;586-591.
33. Rahimian R., Dube G.P., Toma W., Dos Santos N., McManus B.M., van Breemen C. Raloxifene enhances nitric oxide release in rat aorta via increasing endothelial nitric oxide mRNA expression. Eur. J. Pharmacol. 434:2002;141-149.
34. Rosenfeld C.R., White R.E., Roy T., Cox B.E. Calcium-activated potassium channels and nitric oxide coregulate estrogen-induced vasodilation. Am. J. Physiol.: Heart Circ. Physiol. 279:2000;H319-H328.
35. Rosenfeld C.R., Roy T., Cox B.E. Mechanisms modulating estrogen-induced uterine vasodilation. Vasc. Pharmacol. 38:2002;115-125.
36. Shan J., Resnick L.M., Liu Q.Y., Wu X.C., Barbagallo M., Pang P.K.T. Vascular effects of 17β-estradiol in male Sprague-Dawley rats. Am. J. Physiol.: Heart Circ. Physiol. 266:1994;H967-H973.
37. Song J., Standley P.R., Zhang F., Joshi D., Gappy S., Sowers J.R., Ram J.L. Tamoxifen (estrogen antagonist) inhibits voltage-gated calcium current and contractility in vascular smooth muscle from rats. J. Pharmacol. Exp. Ther. 277:1996;1444-1453.
38. 2+ channels. Cell. Physiol. Biochem. 9:1999;242-269.
39. Sudhir K., Ko E., Zellner C., Wong H.E., Hutchison S.J., Chou T.M., Chatterjee K. Physiological concentrations of estradiol attenuate endothelin 1-induced coronary vasoconstriction in vivo. Circulation. 96:1997;3626-3632.
40. 2+ channel blockers. Pharmacology. 65:2002;26-31.
41. + channels to relaxation induced by 17β-estradiol but not by progesterone in isolated rat mesenteric artery rings. J. Cardiovasc. Pharmacol. 41:2003;4-13.
42. Valverde M.A., Rojas P., Amigo J., Cosmelli D., Orio P., Bahamonde M.I., Mann G.E., Vergara C., Latorre R. Acute activation of Maxi-K channels (hSlo) by estradiol binding to the β subunit. Science. 285:1999;1929-1931.
43. 2+ channels. Circ. Res. 81:1997;526-532.
44. + channels. Circ. Res. 79:1996;1024-1030.
45. + channels in human coronary artery smooth muscle cells. Cardiovasc. Res. 53:2002;650-661.
46. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 288:2002;321-333.
47. Zhu Y., Bian Z., Lu P., Karas R.H., Bao L., Cox D., Hodgin J., Shaul P.W., Thoren P., Smithies O., Gustafsson J.A., Mendelsohn M.E. Abnormal vascular function and hypertension in mice deficient in estrogen receptor β Science. 295:2002;505-508.